Skip to content
Recall Observatory FDA recall evidence

Drug product

Bumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0542-11

D-0281-2019

September 19, 2018

Class II

Product summary

Firm
Upsher Smith Laboratories, Inc.
Event
Event 81174
Status
Terminated
Classification
Class II
Quantity
29,080 bottles
Official record key
drug-enforcement:D-0281-2019

Official wording

Reason: Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.

Code information: Lot#: 372461, 372952, 372954, 372955, 373624, 374539, Exp 3/31/2020; 375719, 375721, 376684, Exp 5/31/2020

Distribution pattern: Nationwide USA, Puerto Rico and Guam

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of Specification